Search
Aminorex
go.drugbank.com/drugs/DB01490ExperimentalIllicitAminorex is an amphetamine-like anorectic agent. It may cause pulmonary hypertension.
Amfecloral
go.drugbank.com/drugs/DB08924ExperimentalAmfecloral is a stimulant drug of the phenethylamine and amphetamine chemical classes. … This would produce an effect similar to the amphetamine/barbiturate combinations previously used in psychiatric medications.
Famprofazone
go.drugbank.com/drugs/DB16702Experimental[L34724] It is important to note that the drug is metabolized to [methamphetamine] and [amphetamine] in the body and can lead to positive tests results for illicit drug use.
Categories: AmphetaminesCathinone
go.drugbank.com/drugs/DB01560ExperimentalIllicitCathinone differs from many other amphetamines in that its structure is a ketone. … Closely related to ephedrine, cathine and other amphetamines, it is probably the main contributor to the stimulant effect of Catha edulis.
Narcolepsy
go.drugbank.com/conditions/DBCOND0017525Drugs: Amphetamine · Armodafinil · Dextroamphetamine · Ephedrine · Metamfetamine · Methylphenidate +1 moreLobeline
go.drugbank.com/drugs/DB05137InvestigationalAn alkaloid that has actions similar to nicotine on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, a...
Serdexmethylphenidate
go.drugbank.com/drugs/DB16629Approvedof ADHD is unclear but likely involves dysfunction in dopaminergic and noradrenergic neurotransmission, as evidenced by the clear beneficial effect of CNS stimulants such as [methylphenidate] and [amphetamine
Methenamine
go.drugbank.com/drugs/DB06799ApprovedInvestigationalVet approvedMethenamine is a heterocyclic organic compound with a cage-like structure similar to adamantane. In salt form it is used for the treatment of urinary tract infection (Example: methenamine hippurate which is the hippuric acid salt of meth...
Mixtures: Utac, UtaPanobacumab
go.drugbank.com/drugs/DB15342InvestigationalPanobacumab is under investigation in clinical trial NCT00851435 (Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa).